A Clinical Study to Evaluate SM17 in Healthy Participants

NCT07466940 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis
Asthma
Inflammatory Bowel Disease

Interventions

BIOLOGICAL: SM17
DRUG: SM17 placebo

Sponsor

SinoMab BioScience Ltd